J P Whisnant. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAnticoagulants/therapeutic useAspirin/therapeutic useBlood PlateletsCanadaCerebrovascular Disorders/drug therapyCerebrovascular Disorders/epidemiologyClinical Trials as TopicCoronary Disease/surgeryEndarterectomyHumansIschemic Attack, TransientMaleSulfinpyrazone/therapeutic use
Substances: See more » AnticoagulantsAspirinSulfinpyrazone
Year: 1980 PMID: 6985763 DOI: 10.1016/0002-8703(80)90323-3
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749